Shreya Bhandari, & Hasmitha Kamineni. (2021). Utilization of Intravenous (IV) Curcumin, Genistein, and Trastuzumab to Reduce HER2 receptors in Breast Cancer Patients. International Journal for Research in Applied Sciences and Biotechnology, 8(4), 104–109. Retrieved from https://ijrasb.com/index.php/ijrasb/article/view/204